Skip to content
10-Q

Quarterly Report

BIOCLINICA INC

0001104659-12-076422

← back to feed
Filed
Nov 9, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Oct 31, 2012 15.61M sh
Shares Diluted Q3 2012 · Sep 30, 2012 16.46M sh
Shares Diluted Q3 2012 · Sep 30, 2012 16.47M sh
Shares Diluted Q3 2012 · Sep 30, 2011 16.38M sh
Shares Diluted Q3 2012 · Sep 30, 2011 16.52M sh
Capex Q3 2012 · Sep 30, 2012 $3.31M
Capex Q3 2012 · Sep 30, 2011 $1.35M
Operating Cash Flow Q3 2012 · Sep 30, 2012 $6.01M
Operating Cash Flow Q3 2012 · Sep 30, 2011 $5.9M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $13.18M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $12.58M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $12.29M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $10.44M
Stockholders Equity Q3 2012 · Sep 30, 2012 $60.87M
Stockholders Equity Q3 2012 · Dec 31, 2011 $58.06M
Current Liabilities Q3 2012 · Sep 30, 2012 $25.27M
Current Liabilities Q3 2012 · Dec 31, 2011 $24.75M
Total Liabilities Q3 2012 · Sep 30, 2012 $34.93M
Total Liabilities Q3 2012 · Dec 31, 2011 $32.36M
Current Assets Q3 2012 · Sep 30, 2012 $39.54M
Current Assets Q3 2012 · Dec 31, 2011 $36.31M
Total Assets Q3 2012 · Sep 30, 2012 $95.8M
Total Assets Q3 2012 · Dec 31, 2011 $90.42M
Eps Diluted Q3 2012 · Sep 30, 2012 $0.03
Eps Diluted Q3 2012 · Sep 30, 2012 $0.16
Eps Diluted Q3 2012 · Sep 30, 2011 $0.02
Eps Diluted Q3 2012 · Sep 30, 2011 $0.10
Eps Basic Q3 2012 · Sep 30, 2012 $0.03
Eps Basic Q3 2012 · Sep 30, 2012 $0.16
Eps Basic Q3 2012 · Sep 30, 2011 $0.02
Eps Basic Q3 2012 · Sep 30, 2011 $0.10
Sga Expense Q3 2012 · Sep 30, 2012 $2.7M
Sga Expense Q3 2012 · Sep 30, 2012 $8.08M
Sga Expense Q3 2012 · Sep 30, 2011 $2.43M
Sga Expense Q3 2012 · Sep 30, 2011 $7.03M
Net Income Q3 2012 · Sep 30, 2012 $542K
Net Income Q3 2012 · Sep 30, 2012 $2.57M
Net Income Q3 2012 · Sep 30, 2011 $358K
Net Income Q3 2012 · Sep 30, 2011 $1.63M
Operating Income Q3 2012 · Sep 30, 2012 $1.1M
Operating Income Q3 2012 · Sep 30, 2012 $4.39M
Operating Income Q3 2012 · Sep 30, 2011 $479K
Operating Income Q3 2012 · Sep 30, 2011 $2.53M
Revenue Q3 2012 · Sep 30, 2012 $24.93M
Revenue Q3 2012 · Sep 30, 2012 $70.67M
Revenue Q3 2012 · Sep 30, 2011 $21.47M
Revenue Q3 2012 · Sep 30, 2011 $61.55M